This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Mine were down to 20 from 138, but are now up to 38, geez!
Must be the age.
ohc: sorry they're making you wait so long - "first thing you learn is you always gotta wait"
hcv-research-fans: this year's AASLD conference abstracts are now <a href="http://www.abstractsonline.com/viewer/browseOptions.asp?MKey=%7B201E3AB1%2DB366%2D4CFC%2D879B%2D196DF41D3A21%7D&AKey=%7B704CF973%2DD8A8%2D4909%2DA16B%2D9F7D9FB76BC7%7D">available</a>. Select a day and then find the HCV related sessions. This represents a good deal of this year's fresh crop of new research. Over time, some of it will make its way into refereed journals, clinical reviews, CME summaries and eventually become part of the "standard of care". I don't think hivhepatitis.com and other advocacy sites will start republishing these till after the conference because of a press-embargo.
A couple of highlights : there are two large studies on extended treatment the <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={99753635-F7E5-49BB-BB9A-63350891B720}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={B95B7700-4CCE-45A4-8AB0-70F91E33D429}">teravic-4</a>study done in spain and <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={59C5D3F8-7761-41F4-8C09-0158C9152B37}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={B95B7700-4CCE-45A4-8AB0-70F91E33D429}">another</a> done in Germany. Though the spanish results are more in keeping with the 10% or so reduction in relapse rate one might reasonably guess from what we know so far, they do not yet have their SVR results. The German study does, and it reports no significant benefit from the extended duration. I found this pretty unexpected.. On the plus side both studies reported no major complications (though both used 800mg riba) and, not surprisingly, increased drop out..
Eva Herrman <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={36E90257-8816-41F3-870A-664EE3F924AF}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={B95B7700-4CCE-45A4-8AB0-70F91E33D429}">reports</a> results of an attempt at fine-tuning the current rough cutoff for riba dosage for 1s and finds that 13.75mg/kg provides the best predictive value.
Avidan Neumann has continued <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={96AB3686-2C23-497C-AD8A-DE9119E5C337}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={D0015512-E667-480F-A367-EF109BA6BF10}">tinkering</a> with his early (by week 4) viral kinetic predictors and now has two composite indicators that outperform the current "2-log drop by 12" standard at the cost of at most 3 more VL tests.
Those of us who deal with depression as major side will be amused by two conflicting studies: depression either <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={86D6D462-9587-4271-927D-A52B246F791F}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={B95B7700-4CCE-45A4-8AB0-70F91E33D429}">reduces</a> or <a href="http://www.abstractsonline.com/viewer/viewAbstract.asp?CKey={55EE4300-3173-4980-BB70-70273EBAE17F}&MKey={201E3AB1-B366-4CFC-879B-196DF41D3A21}&AKey={704CF973-D8A8-4909-A16B-9F7D9FB76BC7}&SKey={7E8FD93F-7CF7-481C-A64A-400860F4CD65}">improves</a> our chances of SVR..
Encouraging results on biln-2061 and vx-950 tests, and much, much more... if you find anything noteworthy in the pile please post..
relentless